These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22065157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C, Ojeda F, Zeller T, Zengin E, Rupprecht HJ, Lackner KJ, Bickel C, Blankenberg S, Schnabel RB, Westermann D.
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [Abstract] [Full Text] [Related]

  • 3. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P.
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium.
    Roos M, Schuster T, Ndrepepa G, Baumann M, Lutz J, Braun S, Martinof S, Schömig A, Heemann U, Kastrati A, Hausleiter J.
    Heart Vessels; 2012 Jul; 27(4):352-9. PubMed ID: 21725669
    [Abstract] [Full Text] [Related]

  • 8. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
    Walter T, Brueckmann M, Lang S, Sauer T, Fiedler E, Papassotiriou J, Behnes M, Elmas E, Borggrefe M, Bertsch T.
    Clin Lab; 2010 Jul; 56(7-8):303-9. PubMed ID: 20857894
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, Davies J, Bergmann A, Ng LL.
    J Am Coll Cardiol; 2007 Apr 10; 49(14):1525-32. PubMed ID: 17418290
    [Abstract] [Full Text] [Related]

  • 11. Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study.
    Funke-Kaiser A, Mann K, Colquhoun D, Zeller T, Hunt D, Simes J, Sullivan D, Sydow K, West M, White H, Blankenberg S, Tonkin AM, LIPID Study Investigators.
    Int J Cardiol; 2014 Mar 15; 172(2):411-8. PubMed ID: 24508492
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M, Seyfarth HJ, Wilkens H, Ewert R, Bollmann T, Dinter C, Hertel S, Klose H, Opitz C, Grünig E, Höffken G, Halank M.
    Lung; 2015 Dec 15; 193(6):901-10. PubMed ID: 26363916
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
    Neumann JT, Tzikas S, Funke-Kaiser A, Wilde S, Appelbaum S, Keller T, Ojeda-Echevarria F, Zeller T, Zwiener I, Sinning CR, Jagodzinski A, Schnabel RB, Lackner KJ, Münzel T, Blankenberg S, Wild PS, Sydow K.
    Atherosclerosis; 2013 Jun 15; 228(2):451-9. PubMed ID: 23562132
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pro B-type Natriuretic Peptide and Midregional Proadrenomedullin are Associated with Incident Carotid Stenosis During Long Term Follow-up.
    Fatemi S, Acosta S, Zarrouk M, Engström G, Melander O, Gottsäter A.
    J Stroke Cerebrovasc Dis; 2021 Jan 15; 30(1):105403. PubMed ID: 33160126
    [Abstract] [Full Text] [Related]

  • 18. Midregional proadrenomedullin (MR-proADM) is a powerful predictor of early death in AL amyloidosis.
    Palladini G, Barassi A, Perlini S, Milani P, Foli A, Russo P, Albertini R, Obici L, Lavatelli F, Sarais G, Casarini S, Moratti R, Melzi d'Eril GV, Merlini G.
    Amyloid; 2011 Dec 15; 18(4):216-21. PubMed ID: 22070520
    [Abstract] [Full Text] [Related]

  • 19. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S, Keller T, Ojeda FM, Zeller T, Wild PS, Lubos E, Kunde J, Baldus S, Bickel C, Lackner KJ, Münzel TF, Blankenberg S.
    Heart; 2013 Mar 15; 99(6):388-95. PubMed ID: 23213173
    [Abstract] [Full Text] [Related]

  • 20. Midregional pro-adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study.
    Potocki M, Breidthardt T, Reichlin T, Morgenthaler NG, Bergmann A, Noveanu M, Schaub N, Uthoff H, Freidank H, Buser L, Bingisser R, Christ M, Mebazaa A, Mueller C.
    Crit Care; 2009 Mar 15; 13(4):R122. PubMed ID: 19627611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.